Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Sources
Sources
Web search
Products 101 to 110 of 130
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Rose Oil From Yeast
by
Ginkgo Bioworks
Biotech components:
Microbe
+
Yeast
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/11/28 16:10 (7 years ago)
Known funding amount:
9,000,000 USD
Funding types:
Private Funding
Industry:
Novelty
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Other
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Salk Ideal Plants
by
Salk Institute for Biological Studies
Biotech components:
Gene Editing
+
Plant
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:08 (6 years ago)
Date last modified:
2019/09/12 15:08 (6 years ago)
Known funding amount:
N/A
Funding types:
Public Funding
Industry:
Ecosystem Restoration
+
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Plant
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Salt Tolerant Carrots
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:52 (7 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Salt Tolerant Potatoes
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:53 (7 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Salt Tolerant Tomatoes
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:52 (7 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Self-Limiting Diamondback Moth
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (6 years ago)
Date last modified:
2019/09/12 14:53 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Animal
+
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Fall Armyworm
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (6 years ago)
Date last modified:
2019/09/12 14:53 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Ecosystem Restoration
+
Food & Agriculture
+
Health
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Medfly
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (6 years ago)
Date last modified:
2019/09/12 14:53 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Spotted-Wing Drosophila
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (6 years ago)
Date last modified:
2019/09/12 14:53 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
SNS-301 (noninfectious lambda bacteriophage viruses)
by
Sensei Biotherapeutics
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (5 years ago)
Date last modified:
2020/12/18 14:40 (5 years ago)
Known funding amount:
28,500,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
1
…
4
5
6
7
8
9
10
11
12
13
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
